Metabolic dysfunction in pulmonary hypertension: from basic science to clinical practice Source: Eur Respir Rev, 26 (146) 170094; 10.1183/16000617.0094-2017 Year: 2017
A new era in idiopathic pulmonary fibrosis: considerations for future clinical trials Source: Eur Respir J 2015; 46: 243-249 Year: 2015
Diagnostic evaluation of paediatric pulmonary hypertension in current clinical practice Source: Eur Respir J 2013; 42: 689-700 Year: 2013
Perspectives of therapeutic innovation from current progress in the pathobiology of pulmonary hypertension Source: ERS Course 2020 - Pulmonary hypertension and pulmonary vascular disease Year: 2020
Assessing the effect of medical therapy in COPD: from pathophysiology and biomarkers to clinical practice Source: Annual Congress 2009 - PG15 The complexity of COPD: assessment and advanced therapies Year: 2009
The changing epidemiology of pulmonary hypertension: disease characteristics and clinical outcome over two decades of the swiss registry Source: Virtual Congress 2021 – Pulmonary hypertension in the COVID-19 pandemic and beyond Year: 2021
Diagnosing sarcoidosis: recent advances and international guidelines Source: Annual Congress 2012 - PG8 State-of-the-art management of sarcoidosis Year: 2012
Paediatric pulmonary hypertension: monitoring progress and identifying unmet needs Source: Eur Respir Rev 2009; 18: 18-23 Year: 2009
Recent advances in COPD: pathophysiology, respiratory physiology and clinical aspects, including comorbidities Source: Eur Respir Rev 2009; 18: 198-212 Year: 2009
The definition of pulmonary hypertension: history, practical implications and current controversies Source: Breathe, 17 (3) 210076; 10.1183/20734735.0076-2021 Year: 2021
Pulmonary rehabilitation: recent developments Source: ISSN=ISSN 1810-6838, ISBN=, page=56 Year: 2007
Idiopathic pulmonary fibrosis: do scientists focus on publishing rather than on clinical relevance? Source: Eur Respir J, 55 (6) 2000811; 10.1183/13993003.00811-2020 Year: 2020
Pro: The current classification of pulmonary hypertension meets clinical practice Source: Virtual Congress 2021 – The current classification of pulmonary hypertension meets clinical practice Year: 2021
Introduction: CPET in clinical practice. Recent advances, current challenges and future directions Source: Eur Respir Monogr 2018; 80: x-xxv Year: 2018
Advances in the clinical prediction rules that are used to assess patients with possible pulmonary embolism Source: International Congress 2018 – Advances in idiopathic pulmonary fibrosis treatment, tracheobronchial reconstruction using bioengineering and clinical prediction rules for diagnosing pulmonary embolism Year: 2018
Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives Source: Eur Respir J, 53 (1) 1801887; 10.1183/13993003.01887-2018 Year: 2019
The disease model: implications for clinical practice Source: Eur Respir J, 51 (4) 1800188; 10.1183/13993003.00188-2018 Year: 2018
Pulmonary arterial hypertension registries: past, present and into the future Source: Eur Respir Rev, 28 (154) 190128; 10.1183/16000617.0128-2019 Year: 2019